Get startedLog in
    Picture of H Lundbeck A/S logo

    HLUN A — H Lundbeck A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareBalancedLarge CapNeutral
    All News

    Brief: Lundbeck Announces Advancement Of Lu AG09222 Clinical Development

    Picture of H Lundbeck A/S logoH Lundbeck A/S
    15/03/2024 08:05
    March 15 (Reuters) - H Lundbeck A/S  HLUNb.CO :
    * LUNDBECK'S POTENTIAL FIRST-IN-CLASS THERAPY FOR MIGRAINE
PREVENTION ENTERS ADVANCED CLINICAL STAGE
    * LU AG09222 MAY OFFER A POTENTIAL TREATMENT OPTION IN A NEW
TREATMENT CLASS FOR PEOPLE WITH MIGRAINE

Source text for Eikon:  ID:nWkr1ShPjq 
Further company coverage:  HLUNb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on H Lundbeck A/S

    See all news